{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:27:31Z","timestamp":1728620851313},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.reumae.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:20:01Z","timestamp":1728598801000},"page":"452-453","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adalimumab treatment of resistant chondrocalcinosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Fatih","family":"Tastekin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2024.09.007_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.matbio.2018.05.005","article-title":"Cartilage diseases","volume":"71\u201372","author":"Krishnan","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.reumae.2024.09.007_bib0060","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1056\/NEJMra1511117","article-title":"Calcium pyrophosphate deposition disease","volume":"374","author":"Rosenthal","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reumae.2024.09.007_bib0065","doi-asserted-by":"crossref","unstructured":"Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563-70, https:\/\/doi.org\/10.1136\/ard.2010.139105 [Epub 7.01.2011; PMID: 21216817].","DOI":"10.1136\/ard.2010.139105"},{"key":"10.1016\/j.reumae.2024.09.007_bib0070","first-page":"1001","article-title":"Biologics in the treatment of calcium pyrophosphate deposition disease: a systematic literature review","volume":"38","author":"Cipolletta","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2024.09.007_bib0075","doi-asserted-by":"crossref","first-page":"101720","DOI":"10.1016\/j.berh.2021.101720","article-title":"Calcium pyrophosphate deposition (CPPD) disease \u2013 treatment options","volume":"35","author":"Stack","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.reumae.2024.09.007_bib0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10067-018-4272-2","article-title":"Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases","volume":"38","author":"Thomas","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2024.09.007_bib0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbspin.2017.04.008","article-title":"Interleukin-6 pathway blockade as an option for managing refractory cases of crystal arthritis: two cases report","volume":"85","author":"Quilis","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.reumae.2024.09.007_bib0090","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/annrheumdis-2020-217188","article-title":"Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study","volume":"79","author":"Latourte","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2024.09.007_bib0095","first-page":"536856","article-title":"Effectiveness and safety of infliximab in two cases of severe chondrocalcinosis: nine years of follow-up","volume":"2014","author":"Bruges-Armas","year":"2014","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.reumae.2024.09.007_bib0100","doi-asserted-by":"crossref","first-page":"264859","DOI":"10.1155\/2014\/264859","article-title":"The emerging role of biotechnological drugs in the treatment of gout","volume":"2014","author":"Cavagna","year":"2014","journal-title":"Biomed Res Int"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574324001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574324001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:50:28Z","timestamp":1728600628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574324001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2173574324001163"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2024.09.007","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adalimumab treatment of resistant chondrocalcinosis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\ufffdola de Reumatolog\ufffda (SER), Colegio Mexicano de Reumatolog\ufffda (CMR) and Elsevier Espa\ufffda, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}